Semi-Annual Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7734310

Concept 2016-06-01 to
2017-05-31
As at
2017-05-31
2015-06-01 to
2016-05-31
As at
2016-05-31
As at
2015-05-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
5,456,743,000 JPY
4,290,089,000 JPY
Interest and dividends received
67,192,000 JPY
59,168,000 JPY
Interest paid
-28,485,000 JPY
-40,536,000 JPY
Income taxes paid
-767,146,000 JPY
-1,411,575,000 JPY
Net cash provided by (used in) operating activities
5,069,743,000 JPY
2,948,858,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,992,150,000 JPY
-3,948,608,000 JPY
Purchase of investment securities
JPY
-48,957,000 JPY
Proceeds from sale of investment securities
JPY
7,667,000 JPY
Other, net
-19,677,000 JPY
-25,253,000 JPY
Net cash provided by (used in) investing activities
-3,011,827,000 JPY
-4,015,152,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
2,300,000,000 JPY
2,500,000,000 JPY
Repayments of long-term borrowings
-2,335,465,000 JPY
-2,622,287,000 JPY
Purchase of treasury shares
-670,000 JPY
-2,300,000 JPY
Dividends paid
-375,259,000 JPY
-374,599,000 JPY
Net cash provided by (used in) financing activities
-1,777,711,000 JPY
526,301,000 JPY
Effect of exchange rate change on cash and cash equivalents
-14,002,000 JPY
-27,621,000 JPY
Net increase (decrease) in cash and cash equivalents
266,201,000 JPY
-567,613,000 JPY
Cash and cash equivalents
1,617,337,000 JPY
1,351,135,000 JPY
1,918,749,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.